Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial.

Detre SI, Ashley S, Mohammed K, Smith IE, Powles TJ, Dowsett M.

Cancer Prev Res (Phila). 2017 Mar;10(3):171-176. doi: 10.1158/1940-6207.CAPR-16-0247-T. Epub 2017 Jan 18.

2.

Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution.

Thorpe PE, Detre SI, Foxwell BM, Brown AN, Skilleter DN, Wilson G, Forrester JA, Stirpe F.

Eur J Biochem. 1985 Feb 15;147(1):197-206.

3.

The use of anti-ricin antibodies to protect mice intoxicated with ricin.

Foxwell BM, Detre SI, Donovan TA, Thorpe PE.

Toxicology. 1985 Jan;34(1):79-88.

PMID:
3969682
4.

Monoclonal antibody therapy: "model" experiments with toxin-conjugated antibodies in mice and rats.

Thorpe PE, Detre SI, Mason DW, Cumber AJ, Ross WC.

Haematol Blood Transfus. 1983;28:107-11. No abstract available.

PMID:
6862298
5.

Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin.

Thorpe PE, Brown AN, Ross WC, Cumber AJ, Detre SI, Edwards DC, Davies AJ, Stirpe F.

Eur J Biochem. 1981 Jun 1;116(3):447-54.

6.

Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours.

Grigor KM, Detre SI, Kohn J, Neville AM.

Br J Cancer. 1977 Jan;35(1):52-8.

7.

Secretion of immunoreactive calcitonin by human breast carcinomas.

Coombes RC, Easty GC, Detre SI, Hillyard CJ, Stevens U, Girgis SI, Galante LS, Heywood L, Macintyre I, Neville AM.

Br Med J. 1975 Oct 25;4(5990):197-9.

8.

Letter: Comparison of plasma carcinoembryonic antigen and alpha-fetoprotein in various tumours.

Grigor KM, Detre SI, Laurence DJ, Stevens U, Neville AM.

Lancet. 1975 Aug 30;2(7931):412. No abstract available.

PMID:
51219
9.

Supplemental Content

Loading ...
Support Center